01428nam 2200433 a 450 991013923640332120230803023627.01-118-35459-11-118-35458-31-299-24195-61-118-35457-5(OCoLC)828793860(MiAaPQ)EBC1119446(Au-PeEL)EBL1119446(CaPaEBR)ebr10662566(CaONFJC)MIL455445(EXLCZ)99256000000009819220121002d2013 uy 0engur|n|---|||||Fusion protein technologies for biopharmaceuticals[electronic resource] applications and challenges /edited by Stefan R. SchmidtHoboken, N.J. J. Wiley & Sonsc20131 online resource (654 p.)0-470-64627-6 Includes bibliographical references and index.pt. 1. Introduction -- pt. 2. The triple t paradigm : time, toxin, targeting -- pt. 3. Beyond the triple t-paradigm.Recombinant proteinsBiopharmaceuticsRecombinant proteins.Biopharmaceutics.615.7Schmidt Stefan R174542MiAaPQMiAaPQMiAaPQBOOK9910139236403321Fusion protein technologies for biopharmaceuticals2079722UNINA